Cherry Biotech
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
566 4,454Activities
Technologies
Entity types
Location
93100 Montreuil, France
Montreuil
France
Employees
Scale: 11-50
Estimated: 23
SIREN
801463902Engaged corporates
5
3 0Added in Motherbase
6 years, 2 months ago
biotech Value proposition
Alternative to Animal Testing for Drug Development
Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing.
Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates.
By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert a standard 2D multi-well plate into a 3D cell culture (Organ on Well).
This innovative patented technology allows for the implementation of the current regulatory change on the ethics of animal experimentation while remaining compatible with the current industry workflow.
Cherry Biotech is among the innovative projects selected and supported by the Paris Saclay Cancer Cluster (PSCC), whose mission is to accelerate the development of innovation in oncology.
(Cherry Biotech compte parmi les projets innovants sélectionnés et
accompagnés par le Paris Saclay Cancer Cluster, dont la mission est d’accélérer le développement de l’innovation en oncologie.)
biotechnology, diabetes type 2, in vitro, microphysiological system, pharmaceutical, research, organ on a chip, liver on a chip, drug development, toxicology, preclinical phase, microenvironment controller, animal testing alternative, precision medicine, 3D cell culture, 3D in vitro CRO, and Contract Research Organization (CRO)Original language
Alternative to Animal Testing for Drug Development
Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing.
Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates.
By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert a standard 2D multi-well plate into a 3D cell culture (Organ on Well).
This innovative patented technology allows for the implementation of the current regulatory change on the ethics of animal experimentation while remaining compatible with the current industry workflow.
Home - Cherry Biotech
Pioneering 3D Cell Culture & Alternatives to Animal Testing to Revolutionize Pre-clinical Drug Testing. Redefining Innovation for Ethical & Precise Research
https://www.cherrybiotech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 5 Dec 2024 | | |
 European Bioinformatics Institute | EMBL-EBI Research, Software Development | European Bioinformatics Institute | EMBL-EBI Research, Software Development | Other 22 Nov 2024 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 22 Jun 2024 | | |
 La French Tech Rennes St Malo Public business cluster, French Tech, Software Development | La French Tech Rennes St Malo Public business cluster, French Tech, Software Development | Other 15 Dec 2020 | | |
 Images & Réseaux Public business cluster, French Cluster, IT Services and IT Consulting | Images & Réseaux Public business cluster, French Cluster, IT Services and IT Consulting | Other 17 Mar 2017 | | |